市場調査レポート
商品コード
1090113
miRNAツールおよびサービスの世界市場規模:製品・サービス別、技術別、エンドユーザー別、地域別予測(2022年~2028年)Global MiRNA Tools and Services Market Size study, By Product and Services, By Technology, By End User, and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
miRNAツールおよびサービスの世界市場規模:製品・サービス別、技術別、エンドユーザー別、地域別予測(2022年~2028年) |
出版日: 2022年06月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界のmiRNAツールおよびサービスの市場規模は、慢性疾患の増加や癌患者の増加、遺伝子治療に向けた最近の資金調達活動、バイオインフォマティクスにおける技術的進歩や研究・臨床試験の増加などによって促進されています。
一方で、miRNAツールに関連する高コストが、予測期間における同市場の成長を阻害する可能性があります。
当レポートでは、世界のmiRNAツールおよびサービス市場を調査しており、市場の概要、市場分析、製品・サービス・技術・エンドユーザー・地域別の分析、および競合情勢など、包括的な情報を提供しています。
List of figures
Global MiRNA Tools and Services Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. MiRNA also known as (micro RNA) refers to a small non-coding gene that regulates the expression of other genes. MiRNAs are involved in different aspects of cellular regulation, including development and differentiation, apoptosis, immune response, and inflammation among others. A miRNA tool and service kit provide convenient tools for researchers to research towards this phenomenon at its most initial level to facilitate them to understand how it works more quickly. The growing incidences of chronic diseases and rising number of cancer cases as well as recent funding activities towards gene therapies are accelerating the global market demand. For instance, according to World Health Organization (WHO)- as of April 2021, worldwide around 41 million people died of Noncommunicable diseases (NCDs) each year, witnessing for around 71% of all deaths globally. Cardiovascular diseases caused the greatest number of deaths around 17.9 million, followed by cancers with 9.3 million, and respiratory diseases with 4.1 million deaths , and diabetes with 1.5 million deaths. Furthermore, the market witnessed new product launches and funding activities. For instance, in February 2019, US based Promega Corporation launched its new Maxwell RSC miRNA Plasma and Serum Kit to purify total circulating RNA, including miRNA, from plasma, serum and enriched exosomes for different advance techniques such as NGS or ddPCR etc. Moreover, in February 2021, Swiss pharmaceuticals major Novartis entered into a grant agreement with the Bill & Melinda Gates Foundation. Under this agreement, the foundation would provide funding for discovery and development of an in vivo gene therapy for treatment of sickle cell disease (SCD). Also, growing technological advancements in bioinformatics and increasing number of research and clinical trials are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high cost associated with miRNA Tools impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global MiRNA Tools, and Services Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growing prevalence of chronic diseases and recent funding activities towards gene therapy research. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising expansion Contract Research Organization (CROs) and growing healthcare infrastructure in the region, would create lucrative growth prospects for the global MiRNA Tools and Services Market across the Asia Pacific region.
Major market players included in this report are:
Agilent Technologies INC.
Bio-Rad Laboratories, Inc.
GeneCopoeia, Inc.
Illumina, Inc.
New England Biolabs
Norgen Biotek Corp.
Promega Corporation
Qiagen N.V.
Thermo Fisher Scientific inc
General Electric Company
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product and Services
Research Tools
Services
By Technology
Extraction Tools
qRT-PCR
NGS
Microarray
Functional Analysis Tools
Others
By End User
Research and Academic Institutes
IVD, Pharma and Biotech Companies
CROs
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global MiRNA Tools and Services Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors